Impressive turnout for folate and SAMe presentation

For the Integrative Healthcare Symposium held last week in New York, Professor Teodoro Bottiglieri, Director of the Center of Metabolomics at Baylor Research Institute in Texas presented: The Role of Folate and S-adenosylmethionine in Neuropsychiatric Disorders, drawing the attention of an impressive audience

The event was well attended, confirming the great interest in folate and S-adenosylmethionine (SAMe), and it was an opportunity to reiterate the extraordinary features of Quatrefolic, the glucosamine salt of (6S)-5-methyltetrahydrofolate, structurally analogous to the reduced and active form of folate, able to support and regulate the methylation cycle ensuring a higher folate uptake.

The speech provided a broad perspective on the role, efficacy and safety of Adonat (S-adenosylmethionine –SAMe) in the treatment of mood impairment, neuropsychiatric disorders and co-morbid medical conditions.

Professor Bottiglieri, a specialist on one carbon metabolism, described symptoms and causes of folate deficiency.

Supported by the results of several clinical trials, he also explained the essential role of B vitamins and methyl-group donors to reduce the symptoms of specific diseases, with particular focus on neurodegenerative disorders.

Featured Companies

Gnosis (more information, website)